NCT03649061 2025-06-19
CareRA2020
Universitaire Ziekenhuizen KU Leuven
Phase 4 Completed
Clinical Trials
12 trialsNCT04255134 2023-05-18
BIORA-PAIN
St George's, University of London
Phase 4 Completed
NCT03589833 2022-10-25
YISTAR
Peking Union Medical College Hospital
Phase 4 Completed
NCT03449758 2022-04-28
SariPRO
Sanofi
Phase 4 Completed
NCT00837434 2021-09-22
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 4 Completed
NCT02092467 2021-08-17
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Pfizer
Phase 4 Completed
NCT01548768 2020-11-27
RHYTHM
Columbia University
Phase 4 Completed
NCT01295151 2016-11-02
SWITCH
University of Leeds
Phase 4 Completed
NCT02519387 2016-07-20
Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
Mundipharma Pharmaceuticals Sdn. Bhd.
Phase 4 Completed
NCT01593332 2012-05-08
Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
Mashhad University of Medical Sciences
Phase 4 Completed
NCT00420927 2012-04-18
OPTIMA
Abbott
Phase 4 Completed
NCT00696059 2008-06-12
HURRAH
Hvidovre University Hospital
Phase 4 Completed